A Study to Evaluate the Safety, Tolerability, and Immunogenicity of MVC-COV1901 or MVC-COV1901(Beta) Against COVID-19

Clinical trial NCT05216601 · COMPLETED

Trial details

NCT number: NCT05216601
Sponsor: Medigen Vaccine Biologics Corp.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

COVID-19 Vaccine

Start date: 2022-05-06
Primary completion: 2022-07-26
Enrollment: 107

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.